Form 4 Tracker
Andrew T. Kaplan

Director, 10% Owner · 1 filing · Latest: Apr 16, 2026

Kailera Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
KLRA
Andrew T. KaplanDirector, 10% OwnerApr 20, 2026
Purchase
$16.008,398,438$134.4M26,255,581